U

Universitatsklinikum Leipzig AoR | Medizinische Klinik III - Rheumatologie

Research site

(Unclaimed)

Location

Universitätsklinikum Leipzig AöR, Rheumatologie, Leipzig, Saxony, Germany

Site insights

Top conditions

Top treatments

JNJ-77242113

Povorcitinib

Methoxsalen

LGX818

GC4419

Selonsertib

MBX-8025

Obeticholic Acid

Pemigatinib

Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 14 total trials

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deu...

Active, not recruiting

Plaque Psoriasis

Drug: Deucravacitinib Matching Placebo

Drug: JNJ-77242113 Matching Placebo

A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis (GUIDE)

The purpose of this study is to demonstrate that Super-Responders (SRe; defined as psoriasis participants who receive on-label guselkumab treatment u...

Active, not recruiting

Psoriasis

Drug: Guselkumab

Drug: Placebo Injection

A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (FIGHT-302)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatmen...

Active, not recruiting

Metastatic Cholangiocarcinoma

Unresectable Cholangiocarcinoma

Drug: Gemcitabine

Drug: Cisplatin

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatm...

Active, not recruiting

Angioedema

Hives

Drug: Placebo

Drug: Povorcitinib